<img alt="" src="https://secure.perk0mean.com/171547.png" style="display:none;">

Quanticate to exhibit and sponsor PSI UK 2021 Conference

Commercial Team

Quanticate is exhibiting at this years PSI Online Conference, 21st - 23rd June 2021 and this years sponsor of the poster session. 

To register for the conference, sign up here.

Read More

Quanticate to speak at Virtual OCT UK 2021 Conference

Commercial Team

Claude Price, Director of Clinical Data Management, will be speaking at the Outsourcing in Clinical Trials UK & Ireland 2021 Virtual Conference on 8th June at 1:50pm. 

Read More

Quanticate to host Roundtable at Arena's Future Trials Forum

Commercial Team

Deepu Joseph, VP of Clinical Data Management, will be hosting a roundtable discussion at the "Future Trials Roundtable Forum: Decentralized, Direct to Patient & Virtual Clinical Trials" on 13th May 2021 at 11:30 am & 12:30 pm EDT on “Virtual trials from a data perspective

Read More

Quanticate to speak at Virtual OCT EU 2021

Commercial Team

Deepu Joseph, VP of Clinical Data Management, will be speaking at the Outsourcing in Clinical Trials Europe 2021 - Virtual Conference on Day 2 (6th May) at 10:30am. 

Read More

Quanticate Announces Major Recruitment Drive

Commercial Team

Quanticate, a leading global data-focused Clinical Research Organization (CRO), has announced a recruitment drive, with 60 roles in statistics and programming being hired over the next 6 months

Read More

Quanticate features on CPhI Podcast on Decentralized Clinical Trials and RSDV

Commercial Team

Quanticate is pleased to feature in the CPhI Monthly Podcast. Deepu Joseph and Fabian Du Fraise spoke with Gareth Carpenter about Decentralized Clinical Trials and the challenges that arise, the importance of clinical data and remote source data verification (RSDV).

Read More

Quanticate appoints Lee Patterson as new Chief Operating Officer

Commercial Team

LONDON (UK) - Quanticate, a leading global data-focused Clinical Research Organization (CRO), has named Lee Patterson as the company's Chief Operating Officer (COO).

Read More

Quanticate Announces new Partnership with Antev Ltd

Commercial Team

Quanticate is pleased to partner with Antev Limited on a Phase II, Open-Label, Multicentre Study Investigating the Pharmacokinetics, Pharmacodynamics, Efficacy and Safety of Teverelix Trifluoroacetate, a GnRH antagonist, in Participants with Advanced Prostate Cancer.

Prostate cancer is one of the most commonly diagnosed cancers and is a major cause of death in men worldwide. GnRH antagonists act by direct inhibition of GnRH receptors and therefore Luteinizing Hormone to reduce testosterone levels.

Quanticate is a Data Specialist CRO who has extensive experience supporting numerous oncology programs, including in prostate cancer. We are very much looking forward to supporting Antev on this important and crucial study by providing specialist statistics, programming, data management and medical writing solutions.

Read More
Topics: client news

Quanticate to chair and join panel discussions at the Virtual SCDM 2020 Conference

Clinical Data Management Team

Deepu Joseph, VP of Clinical Data Management, and Claude Price, Associate Director Clinical Data Management, will be attending the SCDM Annual Conference, 13th - 16th Sep, 2020.

Read More

Congratulations to GSK on the US FDA approval of Rukobia (Fostemsavir) for the treatment of HIV

Commercial Team

Quanticate would like to congratulate GSK on their recent US FDA approval Rukobia (fostemsavir), a first in-class treatment for HIV in adults.  Until now patients had few treatment options available.  Quanticate provided statistical analysis and programming to support GSK on this important program.

Read More
Topics: client news

Quanticate Press Room

Catch up with the latest news from Quanticate.

Most Recent